Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 36,782 shares at $105.06 ($3.9M) on 2025-02-12, disclosed to the SEC on 2025-02-13.
Scheduled sale ($3.9M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.98 | 10,738 | $1.1M | 29.4% |
| 2 | $105.06 | 13,022 | $1.4M | 35.3% |
| 3 | $105.06 | 13,022 | $1.4M | 35.3% |
| Total | $105.33 avg | 36,782 | $3.9M | 100% |
| Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |
| BSX | SELL | 2024-03-19 | $1.9M | — | Filing → |